Updated guidance on use and prioritization of monoclonal antibody therapy for treatment of COVID-19 in adolescents

J Wolf, MJ Abzug, BI Anosike, SB Vora… - Journal of the …, 2022 - academic.oup.com
Abstract Background Starting in November 2020, the US Food and Drug Administration
(FDA) has issued Emergency Use Authorizations (EUAs) for multiple novel virus-neutralizing …

Updated Guidance on Use and Prioritization of Monoclonal Antibody Therapy for Treatment of COVID-19 in Adolescents.

J Wolf, M Abzug, B Anosike, S Vora… - Journal of the …, 2022 - escholarship.org
BACKGROUND: Starting in November 2020, the US Food and Drug Administration (FDA)
has issued Emergency Use Authorizations (EUAs) for multiple novel virus-neutralizing …

Updated Guidance on Use and Prioritization of Monoclonal Antibody Therapy for Treatment of COVID-19 in Adolescents

J Wolf, MJ Abzug, BI Anosike, SB Vora… - Journal of the …, 2022 - academic.oup.com
Abstract Background Starting in November 2020, the US Food and Drug Administration
(FDA) has issued Emergency Use Authorizations (EUAs) for multiple novel virus-neutralizing …

Updated Guidance on Use and Prioritization of Monoclonal Antibody Therapy for Treatment of COVID-19 in Adolescents

J Wolf, MJ Abzug, BI Anosike, SB Vora… - Journal of the …, 2022 - profiles.wustl.edu
Background: Starting in November 2020, the US Food and Drug Administration (FDA) has
issued Emergency Use Authorizations (EUAs) for multiple novel virus-neutralizing …

Updated Guidance on Use and Prioritization of Monoclonal Antibody Therapy for Treatment of COVID-19 in Adolescents

J Wolf, MJ Abzug, BI Anosike… - Journal of the …, 2022 - mayoclinic.elsevierpure.com
Background: Starting in November 2020, the US Food and Drug Administration (FDA) has
issued Emergency Use Authorizations (EUAs) for multiple novel virus-neutralizing …

Updated Guidance on Use and Prioritization of Monoclonal Antibody Therapy for Treatment of COVID-19 in Adolescents

J Wolf, MJ Abzug, BI Anosike, SB Vora… - Journal of the Pediatric …, 2022 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Background</jats: title>< jats: p>
Starting in November 2020, the US Food and Drug Administration (FDA) has issued …

[PDF][PDF] Updated Guidance on Use and Prioritization of Monoclonal Antibody Therapy for Treatment of COVID-19 in Adolescents

J Wolf, MJ Abzug, BI Anosike, SB Vora, A Waghmare… - 2022 - researchgate.net
Updated Guidance on Use and Prioritization of Monoclonal Antibody Therapy for Treatment of
COVID-19 in Adolescents Page 1 Monoclonal Antibodies for Pediatric COVID-19 • JPIDS …

Updated Guidance on Use and Prioritization of Monoclonal Antibody Therapy for Treatment of COVID-19 in Adolescents

J Wolf, MJ Abzug, BI Anosike… - Journal of the …, 2022 - einstein.elsevierpure.com
Background: Starting in November 2020, the US Food and Drug Administration (FDA) has
issued Emergency Use Authorizations (EUAs) for multiple novel virus-neutralizing …

Updated guidance on use and prioritization of monoclonal antibody therapy for treatment of COVID-19 in adolescents.

J Wolf, MJ Abzug, BI Anosike, SB Vora, A Waghmare… - 2022 - cabidigitallibrary.org
Abstract Background: Starting in November 2020, the US Food and Drug Administration
(FDA) has issued Emergency Use Authorizations (EUAs) for multiple novel virus-neutralizing …

Updated Guidance on Use and Prioritization of Monoclonal Antibody Therapy for Treatment of COVID-19 in Adolescents.

J Wolf, MJ Abzug, BI Anosike, SB Vora… - Journal of the …, 2022 - search.ebscohost.com
Abstract Background Starting in November 2020, the US Food and Drug Administration
(FDA) has issued Emergency Use Authorizations (EUAs) for multiple novel virus-neutralizing …